Latest Capital Raises News

Wia Gold Limited reports strong drilling results at its Kokoseb Gold Project in Namibia and advances exploration in Côte d'Ivoire, backed by a A$30 million capital raise to fund an expanded 2025 development program.

Rox Resources has advanced its Youanmi Gold Project with a $27 million capital raise and a major drilling campaign, positioning the company for production by late 2025.

Empire Energy Group Limited reported a significant cash outflow of $14.2 million in the December 2024 quarter, driven by exploration and evaluation activities, yet maintains a strong liquidity position with nearly $54 million in available funding.

Viking Mines has unveiled a high-grade inferred mineral resource of 19,000 ounces at its historic First Hit Gold Mine, alongside ongoing drilling and a strong cash position following a recent capital raise.

Sprintex has locked in A$30 million in distribution agreements across the UK, Turkiye, and India, while advancing its innovative G25 Jet Blower launch, signaling a strong growth trajectory in energy-efficient technologies.

Aurora Labs has secured significant contracts in the Defence sector, advancing its micro gas turbine technology and expanding production capabilities following a successful capital raise.

Kincora Copper Limited has unveiled an updated investor presentation outlining its aggressive push towards Tier-1 copper-gold discoveries, backed by over $60 million in partner funding and ramped-up drilling programs across New South Wales and Mongolia.

Complii FinTech Solutions Ltd reports a robust Q2 FY25 with a $3.048 million cash balance, a net operational cash inflow, and a 12.9% year-on-year increase in Annual Recurring Revenue, driven by strategic divestment and focused growth initiatives.

Thor Energy PLC advances its clean energy ambitions through a strategic acquisition in South Australia's hydrogen sector and promising uranium drilling results in the US.

Zelira Therapeutics has received a fourth funding tranche, bringing total investment to US$3.25 million to support FDA clinical trials of its HOPE® 1 cannabinoid medicine targeting irritability in autism spectrum disorder and Phelan-McDermid Syndrome.

Imperial Pacific Limited reports a $652,000 net gain for the half year ending December 31, 2024, driven by strong investment performance and an increased dividend, despite ongoing challenges with its Excelsior Capital stake.

Argosy Minerals Limited reported a net cash outflow in its December 2024 quarter, driven by exploration and evaluation expenses, ending with nearly $6 million in cash reserves.